Navigation Links
Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases
Date:9/27/2010

SAN DIEGO, Sept. 27 /PRNewswire-FirstCall/ -- Amira Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for AM152, a novel LPA1 antagonist.  If accepted, the IND will enable Amira to begin Phase 1 safety studies with the compound in healthy subjects.

"We believe the pre-clinical data obtained to date for AM152 demonstrate characteristics which warrant further studies in humans to determine its potential utility in various fibrotic diseases," said Isabelle DeArmond, Vice President, Clinical Development. "The safety and pharmacokinetic data obtained from Phase 1 studies are an important first step in the clinical investigation of this program."

Added Bob Baltera, Chief Executive Officer, "We are extremely excited to reach this point with our LPA1 program. There have recently been numerous papers published describing the novel biology of the LPA1 receptor and how it relates to abnormal fibrotic processes.  We have worked hard to develop this program and look forward to learning more about this potential therapeutic candidate in a clinical setting."

While there are no LPA1 selective antagonists approved for therapeutic use, there is a strong scientific rationale for this target to be a novel treatment in various fibrotic diseases, including scleroderma and idiopathic pulmonary fibrosis.

About Amira

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.  Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-li
'/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15
2. Visage Imaging Releases Amira 5.3
3. Amira Announces AM103 and AM803 Patent Grant in the United Kingdom
4. Amira Announces Second DP2 Antagonist Patent Grant in the United Kingdom
5. Anti-Fibrotic Data from Amira Pharmaceuticals LPA1 Receptor Antagonist Program Published in the British Journal of Pharmacology
6. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
7. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
8. Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461
9. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
10. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
11. Lotus Pharmaceuticals Announces Two Senior Management Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Inc. (OTC: SIMH, SIMHD) ("Sanomedics" or the "Company"), an ... acquiring cutting-edge technology, products and services announced today that ... booth # 709 at the National Association of ... March 11-13, 2015 at Caesars Palace in ... 36 th annual NAPNAP Conference will bring over ...
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... developing novel therapies for the treatment of chronic ... clinicians and researchers to advisory roles. The panel ... Relmada,s development programs and efforts to advance the ... chronic pain. They bring expertise in a range ...
(Date:3/5/2015)... 5, 2015 LUNGevity Foundation, the nation,s ... Drug Administration,s (FDA) approval of Bristol Myers Squibb,s ... immunotherapy treatments add another critical new treatment option ... of a patient,s own immune system to fight ... specifically for patients with squamous cell lung cancer, ...
Breaking Medicine Technology:Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... MINNEAPOLIS, Oct. 21 In conjunction with National ... Technologies Inc. and Your Safety Company have announced ... Cardiac Arrest Foundation for every HeartSine® samaritan® PAD ... Cardiac Arrest Foundation before December 31, 2009. , ...
... Symmetry Medical Inc. (NYSE: SMA ), a leading independent ... other medical markets, announced today that it will release third ... 2009 before the market opens on Thursday, November 5, 2009. ... a.m. ET on Thursday, November 5, 2009. , A ...
Cached Medicine Technology:HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation 2Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2
(Date:3/5/2015)... INTEGRATED Healthcare Strategies, a trusted ... in its 2015 Children’s Hospitals Executive Compensation Survey. ... positions, and the survey results are exclusive to ... data on 60 executive and director level positions, ... 7 subsidiary children’s hospitals. Additionally, it provided a ...
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic ... Festival and Arnold Fitness EXPO in Columbus, ... host a display booth featuring free samples of its ... highly-popular, class-leading fat burner Synedrex. The company will also ... utilize its top-of-the-line supplements and miniature action figures of ...
(Date:3/5/2015)... Nutrition Leaders, a premier purveyor of health, ... reformulated Millennium 500 Creatine to its customers. Available from ... grade creatine supplement that has been micronized to more ... with overall strength gains in users. , Creatine is ... energy source in the body and helps fuel muscle ...
(Date:3/5/2015)... Jordan Valley Medical Center is now ... option for sudden cardiac arrest. When a patient wears ... detect any life-threatening abnormalities. If an abnormal heart rhythm ... delivering a treatment shock to restore normal rhythm to ... Valley Medical Center and the Heart and Lung Institute ...
(Date:3/5/2015)... USA (PRWEB) March 05, 2015 Kevin ... possible by the grips of drug addiction. The siblings ... support their habits, and to seek refuge during the ... using drugs, without consideration for his outward appearance, hygiene, ... addictive substances. CNY Central reported on Feb. ...
Breaking Medicine News(10 mins):Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 2Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 3
... Feb. 8 "Healing" has become a buzzword in ... book, Healing (Hawk Press, 2010), healer David Elliott ... natural state of balance and harmony that is called love."  The ... says Elliott, "but it,s true - until we love ourselves, we ...
... Ohio A new national study suggests that preschool-aged children ... they regularly engage in one or more of three specific ... and limiting their weekday television viewing time. In a ... 4-year-olds living in homes with all three routines had an ...
... has found that women with medium or low levels ... after being diagnosed with the precancerous breast condition, ductal ... Cancer , a peer-reviewed journal of the American ... hardship may benefit from psychosocial interventions that are designed ...
... ... is a 12-month MBA program focused on executive leadership. Delivered in a blended learning format ... Ken Blanchard EMBA attracts student leaders from all over the US. , ... Phoenix, AZ (PRWEB) February 5, 2010 -- The ...
... may increase the risk of developing asthma after the menopause, ... the journal Thorax . The authors base their ... use of HRT and development of asthma symptoms every two ... taking part in the French E3N study, which includes almost ...
... ... to capture the authentic heartbeat of NY Jets Quarterback Mark Sanchez for a CBS Cares ... stethoscope is a favorite in broadcasting - this may be the biggest audience to hear ... ...
Cached Medicine News:Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 2Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 3Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 4Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 5Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 2Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 3Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 4Health News:Financial hardship contributes to diagnosis anxiety 2Health News:The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February 2Health News:The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February 3Health News:Estrogen-only HRT may increase risk of asthma after menopause 2Health News:Superbowl Heartbeat from Thinklabs Electronic Stethoscope 2
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
This unit is the finest standalone handswitch bipolar unit available....
Standard bipolar coagulator...
...
Medicine Products: